Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Sponsor-related content and external data-sharing links were removed from the page, including Merck branding, IPD sharing URLs, and references to study documents.
    Difference
    20%
    Check dated 2026-09-23T00:36:39.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now shown on the page, replacing the previous Revision: v3.6.6. This indicates an updated page revision of the study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:49:15.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a backend/software update rather than changes to the study information presented.
    Difference
    0.0%
    Check dated 2026-09-01T19:48:02.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new NIH funding entry for 2018 was added to the study's identifiers. This updates the record to reflect U.S. NIH support for KEYNOTE-799.
    Difference
    0.0%
    Check dated 2026-08-25T19:49:58.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, signaling a minor update to the page's build. This does not modify the study details or other user-visible content.
    Difference
    0.0%
    Check dated 2026-08-11T19:30:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new version of the page’s documentation. This reflects an internal update to the page’s revision history rather than a substantive alteration to study details.
    Difference
    0.0%
    Check dated 2026-07-28T12:27:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.